Blog Articles
Stay OCR Ready: Telepsychiatry Privacy and HIPAA for U.S. Clinicians
U.S. clinicians: telepsychiatry privacy and HIPAA steps. Match HHS/OCR expectations with BAAs, secure platforms, consent and breach checks.
Keep Your ADHD Stimulant Rx Through Dec 31, 2026: U.S. Telehealth Rules
How U.S. telehealth lets DEA registered clinicians prescribe ADHD stimulants through Dec 31, 2026, and what patients must do to keep refills.
Clinicians: When to Use Augmentation for Depression, NNT 9–19
Measurement focused clinician summary of antidepressant augmentation: key agents, NNT 9–19, and criteria for escalating to TMS or ketamine.
Antidepressants While Breastfeeding: Clinician Evidence on RID Under 10%
Clinician focused evidence on antidepressant use while breastfeeding. Explains RID thresholds, sertraline and paroxetine safety, and practical infant…
FDA Warns: How U.S. Clinicians Manage Benzodiazepine Dependence Safely
A U.S. clinician explainer on benzodiazepine dependence: what FDA, ASAM, CDC/NIDA say, plus safe outpatient taper steps and when to seek emergency care.
0.5 mg/kg Start: Outpatient Ketamine Infusion Protocol for Clinics
Clinic guide to outpatient IV ketamine using the evidence backed 0.5 mg/kg over 40 minutes regimen. Covers screening, monitoring, dosing schedule, safety,…